The influence of rivaroxaban on markers of fibrinolysis and endothelial cell activation/injury in patients with venous thrombosis

Affiliations

• ¹ Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Department of Haematology, Akershus University Hospital, N-1478 Lørenskog, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway. Electronic address: n.h.schultz@medisin.uio.no.
• ² Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway. Electronic address: pholme@ous-hf.no.
• ³ Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway; Department of Medical Biochemistry, Oslo University Hospital, Norway. Electronic address: carola.henriksson@medisin.uio.no.
• ⁴ Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: UXMAOW@ous-hf.no.
• ⁵ Research Institute of Internal Medicine, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Box 1171, Blindern, N-0318 Oslo, Norway. Electronic address: p.m.sandset@medisin.uio.no.
• ⁶ Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: vibeke.bratset@studmed.uio.no.
• ⁷ Department of Haematology, Oslo University Hospital, Box 4950, Nydalen, N-0424 Oslo, Norway. Electronic address: UXEMJA@ous-hf.no.